Given the neuroprotective properties attributed to M2 macrophages, it is plausible that a shift in the macrophage phenotype towards an M2 state may lead to a substantial boost in TREM2 and APOE synthesis in AD patients. The gene discussed is TREM2; the disease is Alzheimer disease.